Metabolite kinetics in C6 rat glioma model using magnetic resonance spectroscopic imaging of hyperpolarized [1-13C]pyruvate

Magnetic Resonance in Medicine

Volumn 68, Issue 6, 2012, Pages 1886-1893

  Park, Jae Mo ^a,b   Josan, Sonal ^b,c   Jang, Taichang ^b   Merchant, Milton ^b   Yen, Yi Fen ^d   Hurd, Ralph E ^d   Recht, Lawrence ^b   Spielman, Daniel M ^a,b   Mayer, Dirk ^b,c  

^a Stanford University   (United States)

^b STANFORD UNIVERSITY   (United States)

^c SRI INTERNATIONAL   (United States)

^d GE HEALTHCARE   (United States)

Author keywords

glioma metabolism; magnetic resonance spectroscopic imaging; metabolite kinetics

Indexed keywords

CHEMICAL SHIFT; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLISM; METABOLITES; RATE CONSTANTS; RATS; SPIN POLARIZATION;

APPARENT CONVERSION; APPARENT RATE CONSTANT; CHEMICAL SHIFT IMAGING; HYPERPOLARIZED [1; MAGNETIC RESONANCE SPECTROSCOPIC IMAGING; MALIGNANT GLIOMA; METABOLIC MARKERS; SPATIALLY RESOLVED;

TUMORS;

CARBON 13; LACTIC ACID; PYRUVIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOTRANSFORMATION; BRAIN REGION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HYPERPOLARIZATION; KINETICS; METABOLITE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; VASCULARIZATION;

EID: 84870066610     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24181     Document Type: Article

References (38)

1. Wen PY, Kesari S,. Malignant Gliomas in adults. N Eng J Med 2008; 359: 492-507.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO,; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-96.
3. Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Marcello J, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Sampson J, Wagner M, Bailey L, Bigner DD, Friedman AH, Friedman HS,. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 2007; 25: 4722-4729.
4. Lai A, Tran A, Nghiemphu PL, Pope WB, Solis OE, Selch M, Filka E, Yong WH, Mischel PS, Liau LM, Phuphanich S, Black K, Peak S, Green RM, Spier CE, Kolevska T, Polikoff J, Fehrenbacher L, Elashoff R, Cloughesy T,. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma. J Clin Oncol 2011; 29: 142-148.
5. Warburg, O., On the origin of cancer cells. Science 1956; 123: 309-314.
6. Gatenby RA, Gillies RJ,. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4: 891-899.
7. Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, Yoshimura S, Maruyama T, Muragaki Y, Iwama T,. Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. Am J Neuroradiol 2008; 29: 1176-1182.
8. Pauleit D, Stoffels G, Bachofner A, Floeth FW, Sabel M, Herzog H, Tellmann L, Jansen P, Reifenberger G, Hamacher K, Coenen HH, Langen KJ,. Comparison of 18F-FET and 18F-FDG PET in brain tumors. Nucl Med Biol 2009; 36: 779-787.
9. Gambhir SS,. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002; 2: 683-693.
10. Terpstra M, Gruetter R, High WB, Mescher M, DelaBarre L, Merkle H, Garwood M,. Lactate turnover in rat glioma measured by in vivo nuclear magnetic resonance spectroscopy. Cancer Res 1998; 58: 5083-5088.
11. He Q, Bhujwalla ZM, Glickson JD,. Proton detection of choline and lactate in EMT6 tumors by spin-echo-enhanced selective multiple-quantum-coherence transfer. J Magn Reson 1996; 112: 18-25.
12. 1H MR spectroscopy detection of lipids and lactate in metastatic brain tumors. NMR Biomed 1996; 9: 65-71.
13. Star-Lack J, Spielman D, Adalsteinsson E, Kurhanewicz J, Terris DJ, Vigneron DB,. In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5T using PRESS excitation with application to the study of brain and head and neck tumors. J Magn Reson 1998; 133: 243-254.
14. 1H magnetic resonance spectroscopy study. NMR Biomed 1998; 1: 20-26.
15. 13C-1-enriched glucose. Magn Reson Imaging 2010; 28: 690-697.
16. Ardenkjaer-Larson JH, Fridlund B, Gram A, Lerche MH, Servin R, Thaning M, Wolber J,. Increase of signal-to-noise ratio of more than 10,000 times in liquid state NMR. Proc Natl Acad Sci USA 2003; 100: 10158-10163.
17. Golman K, Ardenkjaer-Larsen JH, Petersson JS, Mansson S, Leunbach I,. Molecular imaging with endogenous substances. Proc Natl Acad Sci USA 2003; 100: 10435-10439.
18. 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. J Cancer Res 2008; 68: 8607-8615.
19. Darpolor MM, Yen YF, Chua MS, Xing L, Clarke-Katzenberg RH, Shi W, Mayer D, Josan S, Hurd RE, Pfefferbaum A, Senadheera L, So S, Hofmann LV, Glazer GM, Spielman DM,. In vivo MRSI of hyperpolarized [1-(13)C] pyruvate metabolism in rat hepatocellular carcinoma. NMR Biomed 2011; 24: 506-513.
20. 13C1-pyruvate transport and metabolism in living human breast cancer cells. Proc Natl Acad Sci USA 2009; 106: 18131-18136.
21. Kurhanewicz J, Vigneron DB, Brindle K, Chekmenev EY, Comment A, Cunningham CH, Deberardinis RJ, Green GG, Leach MO, Rajan SS, Rizi RR, Ross BD, Warren WS, Malloy CR,. Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia 2011; 13: 81-97.
22. Hurd RE, Yen YF, Tropp J, Pfefferbaum A, Spielman DM, Mayer D,. Cerebral dynamics and metabolism of hyperpolarized [1-(13)C] pyruvate using time-resolved MR spectroscopic imaging. J Cereb Blood Flow Metab 2010; 30: 1734-1741.
23. Hurd RE, Yen YF, Mayer D, Chen A, Wilson D, Kohler S, Bok R, Vigneron D, Kurhanewicz J, Tropp J, Spielman D, Pfefferbaum A,. Metabolic imaging in the anesthetized rat brain using hyperpolarized [1-13C] pyruvate and [1-13C] ethyl pyruvate. Magn Reson Med 2010; 63: 1137-1143.
24. Park I, Larson PE, Zierhut ML, Hu S, Bok R, Ozawa T, Kurhanewicz J, Vigneron DB, Vandenberg SR, James CD, Nelson SJ,. Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. Neuro-Oncol 2010; 12: 133-144.
25. Park I, Bok R, Ozawa T, Phillips JJ, James CD, Vigneron DB, Ronen SM, Nelson SJ,. Detection of early response to temozolomide treatment in brain tumors using hyperpolarized (13) C MR metabolic imaging. J Magn Reson Imaging 2011; 33: 1284-1290.
26. Day SE, Kettunen MI, Cherukuri MK, Mitchell JB, Lizak MJ, Morris HD, Matsumoto S, Koretsky AP, Brindle KM,. Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1-(13)C] pyruvate and (13)C magnetic resonance spectroscopic imaging. Magn Reson Med 2011; 65: 557-563.
27. Mayer D, Levin YS, Hurd RE, Glover GH, Spielman DM,. Fast metabolic imaging of systems with sparse spectra: application for hyperpolarized 13C imaging. Magn Reson Med 2006; 56: 932-937.
28. Benda P, Lightbody J, Sato G, Levine L, Sweet W,. Differentiated rat glial strain in tissue culture. Science 1968; 161: 370-371.
29. Kubiatowski T, Jang T, Lachyankar MB, Salmonsen R, Nabi RR, Quesenberry PJ, Litofsky NS, Ross AH, Recht LD,. Association of increased phosphatidylinositol-3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas. J Neurosurg 2001; 95: 480-488.
30. Lachyankar MB, Ross AH, Litofsky NS, Condon PJ, Quesenberry PJ, Recht LD,. TrkA expression enhances survival of rats with intracerebral C6 gliomas. Cancer Res 1997; 57: 532-536.
31. Mayer D, Yen YF, Takahashi A, Josan S, Tropp J, Rutt BK, Hurd RE, Spielman DM, Pfefferbaum A,. Dynamic and high-resolution metabolic imaging of hyperpolarized [1-13C]-pyruvate in the rat brain using a high-performance gradient insert. Magn Reson Med 2011; 65: 1228-1233.
32. Chronik B, Alejski A, Rutt BK,. Design and fabrication of a three-axis multilayer gradient coil for magnetic resonance microscopy of mice. MAGMA 2000; 10: 131-146.
33. Derby K, Tropp J, Hawryszko C,. Design and evaluation of a novel dual-tuned resonator for spectroscopic imaging. J Magn Reson 1990; 86: 645-651.
34. Zhao L, Mulkern R, Tseng CH, Williamson D, Patz S, Kraft R, Walsworth RL, Jolesz FA, Albert MS,. Gradient-echo imaging considerations for hyperpolarized 129Xe MR. J Magn Reson B 1996; 113: 179-183.
35. Yen YF, Kohler SJ, Chen AP, Tropp J, Bok R, Wolber J, Albers MJ, Gram KA, Zierhut ML, Park I, Zhang V, Hu S, Nelson SJ, Vigneron DB,. Imaging considerations for in vivo 13C metabolic mapping using hyperpolarized 13C-pyruvate. Magn Reson Med 2009; 62: 1-10.
36. Josan S, Hurd R, Kerr AB, Yen Y-F, Larson PE, Pfefferbaum A, Spielman D, Mayer D,. Effects of RF excitation scheme on signal-to-noise ratio and apparent rate constant estimation in dynamic volumetric imaging of hyperpolarized [1-13C] pyruvate. In: Proceedings of the 19th Annual Meeting of ISMRM, Montreal, Canada, 2011. E-poster 3528.
37. Yen YF, Chen AP, Zierhut ML, Bok R, Zhang VY, Albers MJ, Tropp J, Nelson SJ, Vigneron DB, Kurhanewicz J, Hurd RE,. EPSI sampling strategies for spectroscopic imaging of sparse spectra: applications for hyperpolarized 13C imaging. In: Proceedings of the 15th Annual Meetings of ISMRM, Berlin, Germany, 2007. Abstract 2928.
38. Mieville P, Jannin S, Bodenhausen G,. Relaxometry of intensive nuclei: optimizing dissolution dynamic nuclear polarization. J Magn Reson 2011; 210: 137-140.